BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0080
0.00 (0.00%)
Aug 31, 2026, 4:00 PM EST
BioRegenx Market Cap
BioRegenx has a market cap or net worth of $7.77 million as of September 1, 2026. Its market cap has decreased by -41.82% in one year.
Market Cap
7.77M
Enterprise Value
9.89M
Revenue
1.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
ChartMarket Cap Chart
Since March 12, 2024, BioRegenx's market cap has decreased from 49.89M to 7.77M, a decrease of -84.42%. That is a compound annual growth rate of -52.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 7.77M | -37.37% |
| Dec 31, 2025 | 12.41M | 44.15% |
| Dec 31, 2024 | 8.61M | -82.74% |
| Mar 12, 2024 | 49.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Retrieve Medical Holdings | 29.61M |
| Healixa | 24.92M |
| CareView Communications | 21.62M |
| Pharma-Bio Serv | 12.37M |
| PreAxia Health Care Payment Systems | 9.47M |
| CompuMed | 8.94M |
| DATATRAK International | 8.90M |
| Vynleads | 7.51M |